Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
Authors
Keywords
-
Journal
SAUDI PHARMACEUTICAL JOURNAL
Volume 29, Issue 2, Pages 206-212
Publisher
Elsevier BV
Online
2021-01-29
DOI
10.1016/j.jsps.2021.01.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The characteristics and treatment patterns of patients with Parkinson’s disease in the United States and United Kingdom: A retrospective cohort study
- (2019) Linda Kalilani et al. PLoS One
- Patterns and Determinants of Prescribing for Parkinson’s Disease: A Systematic Literature Review
- (2019) Khalid Orayj et al. Parkinsons Disease
- Antipsychotic Drug-Induced Movement Disorders: A Forgotten Problem?
- (2018) Tamara Pringsheim et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Levodopa: A new look at an old friend
- (2017) C. Warren Olanow et al. MOVEMENT DISORDERS
- Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
- (2016) Jinglin Zhang et al. Current Neuropharmacology
- Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America
- (2016) John L. Goudreau et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Association of guidelines and clinical practice in early Parkinson's disease
- (2016) T. Keränen et al. European Geriatric Medicine
- Trends in inpatient antiparkinson drug use in the USA, 2001–2012
- (2015) James A. G. Crispo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010
- (2014) Sachiko Nakaoka et al. PLoS One
- Initial Medication in Patients of Newly Diagnosed Parkinson’s Disease in Taiwan
- (2014) Yi-Jen Guo et al. PLoS One
- Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
- (2014) T. L. Pitcher et al. Parkinsons Disease
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs Disease
- (2011) Anthony H.V. Schapira CNS DRUGS
- Delayed Parkinson’s Disease Diagnosis among African-Americans: The Role of Reporting of Disability
- (2011) Nabila Dahodwala et al. NEUROEPIDEMIOLOGY
- Impact of recommendations on the initial therapy of Parkinson’s disease: A population-based study in France
- (2011) Claudine Fayard et al. PARKINSONISM & RELATED DISORDERS
- Utilization of anti-Parkinson drugs in Australia: 1995-2009
- (2011) Samantha A Hollingworth et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease
- (2011) M. Mostafa Mokhles et al. PHARMACOLOGICAL RESEARCH
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started